Sex-based Differences in Risk for Therapy-related Myeloid Neoplasms.

Melissa A Richard Chengcheng YanYanjun ChenChristopher J GibsonRashi KalraAlysia Kristine Bosworth David K Crossman Purnima SinghLindsey HagemanJianbo HeSaro H Armenian Julie M Vose Daniel J Weisdorf Benjamin L Ebert Yutaka Yasui Changde Cheng Stephen J Forman Smita Bhatia Ravi Bhatia

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)

Presence of CH mutations in PBSC confers increased risk of t-MN after autologous transplantation in male but not female patients with NHL. Factors underlying sex-based differences in risk of CH progression to t-MN merit further investigation.

Keyphrases

room temperature
bone marrow
cell therapy
dendritic cells
acute myeloid leukemia
metal organic framework
transition metal
ionic liquid
stem cells
immune response
mesenchymal stem cells
replacement therapy